QCG
HCAT icon

Quadrant Capital Group’s Health Catalyst HCAT Stock Holding History

Quadrant Capital Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$87 Sell
68
-22
-24% -$41 ﹤0.01% 2694
2025
Q4 		$216 Sell
90
-34
-27% -$93 ﹤0.01% 2679
2025
Q3 		$353 Buy
+124
New +$424 ﹤0.01% 2634
2025
Q2 		– Sell
-1,945
Closed -$8.81K – 1882
2025
Q1 		$8.81K Buy
1,945
+1,529
+368% +$8.09K ﹤0.01% 2245
2024
Q4 		$2.94K Hold
416
– – ﹤0.01% 2441
2024
Q3 		$3.39K Sell
416
-1,390
-77% -$10K ﹤0.01% 2397
2024
Q2 		$11.5K Buy
1,806
+1,468
+434% +$9.42K ﹤0.01% 2070
2024
Q1 		$2.55K Hold
338
– – ﹤0.01% 2463
2023
Q4 		$3.13K Sell
338
-160
-32% -$1.31K ﹤0.01% 2387
2023
Q3 		$5.04K Sell
498
-1,273
-72% -$15.2K ﹤0.01% 2172
2023
Q2 		$22.1K Buy
1,771
+97
+6% +$1.16K ﹤0.01% 1668
2023
Q1 		$19.5K Sell
1,674
-8
-0.5% -$102 ﹤0.01% 1710
2022
Q4 		$17.9K Buy
1,682
+789
+88% +$7.62K ﹤0.01% 1705
2022
Q3 		$9K Sell
893
-176
-16% -$2.33K ﹤0.01% 1924
2022
Q2 		$15K Buy
1,069
+995
+1,345% +$17K ﹤0.01% 1438
2022
Q1 		$2K Buy
+74
New +$2.1K ﹤0.01% 2152
2021
Q3 		– Sell
-4
Closed – – 2554
2021
Q2 		$0 Buy
+4
New +$213 ﹤0.01% 2469

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Quadrant Capital Group's HCAT Position: Q1 2026 in Review

Quadrant Capital Group reduced its Health Catalyst (HCAT) stake by 24% in Q1 2026, selling an estimated $41 and leaving 68 shares worth $87. The position accounts for ﹤0.01% of the portfolio, ranked #2694.

Quadrant Capital Group first reported a position in HCAT in Q2 2021 and has held it in 17 quarters since. The position peaked at $22.1K in Q2 2023. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Quadrant Capital Group held 68 shares of Health Catalyst worth $87 as of Q1 2026.
  • Quadrant Capital Group sold 22 Health Catalyst shares in Q1 2026, an estimated $41.
  • Health Catalyst made up ﹤0.01% of Quadrant Capital Group's portfolio in Q1 2026, its #2694 holding.
  • Quadrant Capital Group first reported a position in Health Catalyst in Q2 2021 and has held it in 17 quarters since.
  • Quadrant Capital Group's Health Catalyst position peaked at $22.1K in Q2 2023.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.